Keyphrases
Atrial Fibrillation
100%
Stroke Prevention
100%
Thromboembolism Prevention
100%
Warfarin
57%
Anticoagulant Effect
28%
Metabolism
14%
Genetic Variability
14%
Western Countries
14%
Factor Xa Inhibitors
14%
Apixaban
14%
Vitamin K Antagonists
14%
Rivaroxaban
14%
Stroke Risk
14%
Preventing Stroke
14%
Aspirin
14%
Selectivity Factor
14%
Underuse
14%
Invasive Procedures
14%
Clinical Evidence
14%
Blood Assay
14%
Arrhythmia
14%
Pharmacological Properties
14%
Drug Interactions
14%
Clopidogrel
14%
Multiple Drugs
14%
Economic Burden
14%
Major Bleeding
14%
Therapeutic Range
14%
Morbidity Burden
14%
Thromboembolism
14%
Mortality Burden
14%
Atrial Fibrillation Treatment
14%
Direct Thrombin Inhibitors
14%
Narrow Therapeutic Window
14%
Food Interaction
14%
Stroke Reduction
14%
Percutaneous Left Atrial Appendage Closure
14%
Atrial Fibrillation-related Stroke
14%
Dabigatran Etexilate
14%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Thromboembolism
100%
Warfarin
44%
Anticoagulant Agent
22%
Prevalence
11%
Bleeding
11%
Clinical Study
11%
Acetylsalicylic Acid
11%
Therapeutic Window
11%
Heart Arrhythmia
11%
Thrombin Inhibitor
11%
Clopidogrel
11%
Rivaroxaban
11%
Blood Clotting Factor 10a Inhibitor
11%
Apixaban
11%
Antivitamin K
11%
Dabigatran Etexilate
11%